PL2717906T3 - Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek - Google Patents

Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek

Info

Publication number
PL2717906T3
PL2717906T3 PL12729755T PL12729755T PL2717906T3 PL 2717906 T3 PL2717906 T3 PL 2717906T3 PL 12729755 T PL12729755 T PL 12729755T PL 12729755 T PL12729755 T PL 12729755T PL 2717906 T3 PL2717906 T3 PL 2717906T3
Authority
PL
Poland
Prior art keywords
alkaline phosphatase
renal function
preserving renal
preserving
function
Prior art date
Application number
PL12729755T
Other languages
English (en)
Inventor
Jacques Salomon Robert Arend
Den Berg Erik Jan Van
Willem Raaben
Original Assignee
Am-Pharma B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am-Pharma B.V. filed Critical Am-Pharma B.V.
Publication of PL2717906T3 publication Critical patent/PL2717906T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03001—Alkaline phosphatase (3.1.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL12729755T 2011-06-08 2012-06-08 Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek PL2717906T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11169143 2011-06-08
EP12729755.4A EP2717906B1 (en) 2011-06-08 2012-06-08 The use of alkaline phosphatase for preserving renal function

Publications (1)

Publication Number Publication Date
PL2717906T3 true PL2717906T3 (pl) 2017-06-30

Family

ID=46354459

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12729755T PL2717906T3 (pl) 2011-06-08 2012-06-08 Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek
PL17158127T PL3222286T3 (pl) 2011-06-08 2012-06-08 Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17158127T PL3222286T3 (pl) 2011-06-08 2012-06-08 Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek

Country Status (7)

Country Link
US (3) US20140219984A1 (pl)
EP (2) EP3222286B1 (pl)
DK (2) DK2717906T5 (pl)
ES (2) ES2828987T3 (pl)
HU (1) HUE052383T2 (pl)
PL (2) PL2717906T3 (pl)
WO (1) WO2012169892A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4999467B2 (ja) 2004-02-04 2012-08-15 ファルマアウェア セプシス ビー．ブイ． 粘膜関門に存在するｌｐｓを解毒するためのアルカリホスファターゼの使用
US20130261412A1 (en) * 2012-03-28 2013-10-03 II Robert Lawrence Reed System and method for managing fluid levels in patients based upon creatinine clearance
CA2937328C (en) 2014-01-24 2022-09-27 Am-Pharma B.V. Chimeric alkaline phosphatase-like proteins
ES2810813T3 (es) * 2014-01-24 2021-03-09 Am Pharma Bv Procesamiento para recuperación y purificación de una fosfatasa alcalina
WO2016030711A1 (en) * 2014-08-25 2016-03-03 Diasys Diagnostics India Private Limited Stable phosphatase substrate formulation and uses thereof
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
FI3762018T3 (fi) * 2018-03-08 2024-04-22 Am Pharma Bv Rekombinantti alkalinen fosfataasi käytettäväksi sepsikseen liittyvän akuutin munuaisvaurion hoitamiseen
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
US11654184B2 (en) 2018-03-20 2023-05-23 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
JP7660523B2 (ja) 2019-05-06 2025-04-11 セリバ・バイオロジクス・インコーポレイテッド アルカリリン酸塩に基づいた癌治療
CN113667713A (zh) * 2020-05-14 2021-11-19 深圳市长卿医学研究院 一种肾功能损害风险降低的方法及应用
WO2022055350A1 (en) 2020-09-09 2022-03-17 Am-Pharma B.V. Recombinant alkaline phosphatase for use in treating acute respiratory distress syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695714B2 (en) * 2005-12-28 2010-04-13 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
US7718170B2 (en) * 2006-08-21 2010-05-18 Essential Skincare, Llc Alkaline phosphatase compositions to reduce skin cancer
EP1952823A1 (en) * 2007-01-30 2008-08-06 AM-Pharma B.V. The use of alkaline phosphatase in the treatment of reduced renal function
EP1985697A1 (en) 2007-04-27 2008-10-29 AM-Pharma B.V. Modified phosphatases

Also Published As

Publication number Publication date
PL3222286T3 (pl) 2021-04-06
WO2012169892A2 (en) 2012-12-13
WO2012169892A3 (en) 2013-03-14
US20140219984A1 (en) 2014-08-07
DK2717906T3 (en) 2017-03-20
EP3222286A1 (en) 2017-09-27
EP3222286B1 (en) 2020-10-21
EP2717906A2 (en) 2014-04-16
HUE052383T2 (hu) 2021-04-28
US20160250299A1 (en) 2016-09-01
EP2717906B1 (en) 2017-03-01
ES2618794T3 (es) 2017-06-22
DK2717906T5 (en) 2017-06-19
DK3222286T3 (da) 2020-11-09
ES2828987T3 (es) 2021-05-28
US20190209662A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
PL3222286T3 (pl) Stosowanie fosfatazy alkalicznej do zachowywania czynności nerek
GB201117019D0 (en) Herbicidal compounds
GB201206598D0 (en) Herbicidal compounds
GB201205657D0 (en) Herbicidal compounds
PL2793589T3 (pl) Związki herbicydowe
AU345873S (en) Pan
IL228651A0 (en) Herbicidal compounds
GB201205654D0 (en) Herbicidal compounds
IL217461A0 (en) Dump tray
GB201116879D0 (en) Endoprosthesis
ZA201400204B (en) Microbiocidal heterocycles
GB201116152D0 (en) Cannabinoid-2-receptor agonists
PH32011000599S1 (en) Dust pan
GB201219148D0 (en) Herbicidal compounds
GB201205658D0 (en) Herbicidal compounds
GB201205660D0 (en) Herbicidal compounds
GB201205656D0 (en) Herbicidal compounds
GB201205662D0 (en) Herbicidal compounds
GB201204894D0 (en) Herbicidal compounds
GB201204893D0 (en) Herbicidal compounds
GB201204724D0 (en) Herbicidal compounds
GB201204281D0 (en) Herbicidal compounds
GB201204282D0 (en) Herbicidal compounds
GB201203798D0 (en) Herbicidal compounds
GB201203797D0 (en) Herbicidal compounds